Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021Alize J Ferrari, Masayuki Teramoto, Robert Kaba Alhassan et al.|The Lancet|2024Cited by 4.4k
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021Masayuki Teramoto, Muayyad Ahmad, Hansani Madushika Abeywickrama et al.|The Lancet|2025Cited by 801
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021Masayuki Teramoto, Noah Ahmad, George Patton et al.|The Lancet|2025Cited by 316
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019Dongze Wu, Ihsan Ullah Khan Altaf, Yingzhao Jin et al.|EClinicalMedicine|2023Cited by 132
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Salah Al Awaidy, Marissa B Reitsma et al.|The Lancet Public Health|2024Cited by 125